Table 1.
Preprocedural neurological events, cardiovascular risk factors, comorbidities, and previous invasive vascular therapies.
| Patient-Related Parameters | AS Group (N = 40) |
RES Group (N = 26) |
p-Value |
|---|---|---|---|
| Preprocedural neurological events, N (%) | 9 (22.5) | 6 (23.1) | >0.999 |
| Amaurosis fugax, N (%) | 3 (7.5) | 0 (0) | 0.273 |
| TIA, N (%) | 3 (7.5) | 6 (23.1) | 0.139 |
| Minor stroke, N (%) | 3 (7.5) | 0 (0) | 0.273 |
| CV risk factors, comorbidities | |||
| Female sex, N (%) | 3 (7.5) | 10 (38.5) | 0.003 |
| Age ≥ 80 years, N (%) | 5 (12.5) | 2 (7.7) | 0.695 |
| Hypertension, N (%) | 28 (70) | 25 (96.2) | 0.010 |
| Hyperlipidemia, N (%) | 13 (32.5) | 8 (30.8) | >0.999 |
| Diabetes mellitus, N (%) | 8 (20) | 8 (30.8) | 0.384 |
| Chronic kidney disease, N (%) | 2 (5) | 4 (15.4) | 0.202 |
| Previous invasive vascular therapies | |||
| Coronary artery invasive treatment, N (%) | 11 (27.5) | 3 (11.5) | 0.217 |
| Contralateral carotid artery invasive treatment, N (%) | 8 (20) | 13 (50) | 0.015 |
| Subclavian artery invasive treatment, N (%) | 0 (0) | 1 (3.8) | 0.394 |
| Visceral artery invasive treatment, N (%) | 1 (2.5) | 2 (7.7) | 0.557 |
| Aortic invasive treatment, N (%) | 0 (0) | 1 (3.8) | 0.394 |
| Lower extremity arterial invasive treatment, N (%) | 7 (17.5) | 11 (42.3) | 0.046 |
AS, Atherosclerotic; CV, cardiovascular; N, number; RES, restenotic; TIA, transient ischemic attack.